These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7003085)

  • 1. The effects of pancuronium bromide on infants with hyaline membrane disease.
    Crone RK; Favorito J
    J Pediatr; 1980 Dec; 97(6):991-3. PubMed ID: 7003085
    [No Abstract]   [Full Text] [Related]  

  • 2. Aortic root blood flow increases after pancuronium in neonates with hyaline membrane disease.
    Costakos DT; Blackwell CE; Krauss AN; Eisen C; Violaris K; Wiercinski AE; Auld PA
    Crit Care Med; 1991 Feb; 19(2):187-90. PubMed ID: 1899207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute cardiopulmonary effects of pancuronium bromide in mechanically ventilated newborn infants.
    Runkle B; Bancalari E
    J Pediatr; 1984 Apr; 104(4):614-7. PubMed ID: 6707824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancuronium during mechanical ventilation speeds recovery of lungs of infants with hyaline membrane disease.
    Pollitzer MJ; Reynolds EO; Shaw DG; Thomas RM
    Lancet; 1981 Feb; 1(8216):346-8. PubMed ID: 6109989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of morphine and pancuronium on the stress response in ventilated preterm infants.
    Quinn MW; Otoo F; Rushforth JA; Dean HG; Puntis JW; Wild J; Levene MI
    Early Hum Dev; 1992 Oct; 30(3):241-8. PubMed ID: 1468386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of morphine and pancuronium on lung volume and oxygenation in premature infants with hyaline membrane disease.
    Miller J; Law AB; Parker RA; Sundell H; Silberberg AR; Cotton RB
    J Pediatr; 1994 Jul; 125(1):97-103. PubMed ID: 8021797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancuronium attenuates associated hemodynamic and transcutaneous oxygen tension changes during nursery procedures.
    Bada HS; Burnette TM; Arheart KL; Shull N; Mirro R; Korones SB
    J Perinatol; 1995; 15(2):119-23; quiz 124-5. PubMed ID: 7595769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low peak inspiratory pressure for ventilation of infants with hyaline membrane disease.
    Ratner I; Hernandez J; Accurso F
    J Pediatr; 1982 May; 100(5):802-4. PubMed ID: 7040625
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with pancuronium bromide in infants and children.
    Yamamoto T; Baba H; Shiratsuchi T
    Anesth Analg; 1972; 51(6):919-24. PubMed ID: 4264153
    [No Abstract]   [Full Text] [Related]  

  • 10. ASSISTED VENTILATION IN TERMINAL HYALINE MEMBRANE DISEASE.
    DELIVORIA-PAPADOPOULOS M; SWYER PR
    Arch Dis Child; 1964 Oct; 39(207):481-4. PubMed ID: 14223660
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of pancuronium and pethidine on heart rate and blood pressure in ventilated infants.
    Miall-Allen VM; Whitelaw AG
    Arch Dis Child; 1987 Nov; 62(11):1179-80. PubMed ID: 3688927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and catecholamine changes after administration of pancuronium in distressed neonates.
    Cabal LA; Siassi B; Artal R; Gonzalez F; Hodgman J; Plajstek C
    Pediatrics; 1985 Feb; 75(2):284-7. PubMed ID: 3918294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the effects of paralysis by pancuronium on heart rate variability, blood pressure and fluid balance.
    Greenough A; Gamsu HR; Greenall F
    Acta Paediatr Scand; 1989 Nov; 78(6):829-34. PubMed ID: 2603705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can muscle relaxation prevent the development of pneumothorax in artificially ventilated newborn infants?].
    Lischka A; Popow C; Simbruner G
    Wien Klin Wochenschr; 1987 Sep; 99(18):636-8. PubMed ID: 3318144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancuronium and abnormal abdominal roentgenograms.
    Dillard RG; Crowe JE; Sumner TE
    Am J Dis Child; 1980 Sep; 134(9):821-3. PubMed ID: 7416104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vitamin E and bronchopulmonary dysplasia in pulmonary hyaline membrane disease].
    Zanardo V; Romanelli M; Pesenti P; Mittiga S; Marcazzò L; Benini F
    Acta Vitaminol Enzymol; 1982; 4(3):221-6. PubMed ID: 6756098
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular effects of d-tubocurarine and pancuronium in newborn lambs during normoxia and hypoxia.
    Cameron CB; Gregory GA; Rudolph AM; Heymann MA
    Pediatr Res; 1986 Mar; 20(3):246-52. PubMed ID: 3703612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The circulation, fluid transfers and surface activity in the lungs of infants with hyaline membrane disease.
    Normand IC
    Bull Physiopathol Respir (Nancy); 1973; 9(6):1473-94. PubMed ID: 4602246
    [No Abstract]   [Full Text] [Related]  

  • 20. Exogenous surfactant replacement therapy of hyaline membrane disease in premature infants.
    Namgung R; Lee C; Suh JS; Park KI; Han DG
    Yonsei Med J; 1989 Dec; 30(4):355-66. PubMed ID: 2697112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.